BASF at a Crossroads: Citigroup Sees a Turning Point as the Chemical Giant Overhauls Its Portfolio

The Ludwigshafen-based chemical titan is juggling multiple moving parts — a sweeping corporate restructuring, fresh capacity investments in specialty plastics, and a bullish call from Wall Street that puts it at odds with the broader analyst consensus. BASF’s shares are hovering just below their 52-week high, and the next few days could determine whether the rally has further to run.

A Bullish Bet That Stands Alone

Citigroup analyst Sebastian Satz has raised his price target on BASF from €55 to €61, reiterating a “Buy” rating and placing the stock on the bank’s “positive Catalyst Watch” list. Satz argues that a “Goldilocks scenario” is emerging, driven by supply distortions in the market that should provide operational tailwinds. He identifies the second quarter of 2026 as the long-awaited inflection point for earnings growth.

That view is decidedly contrarian. The average analyst price target sits at €52.25 — below the current share price of €54.24, which climbed roughly 2% on Thursday. The stock has now made its third attempt in quick succession to break sustainably above the €55 level, a barrier that has held firm. The 52-week high of €54.70 is less than 1% away.

Since the start of the year, BASF shares have gained more than 21%, trading comfortably above their key moving averages. Yet the Relative Strength Index (RSI) stands at 23.6, a reading that typically signals short-term oversold conditions rather than sustained buying pressure — a technical nuance that complicates the bullish narrative.

A Deeper Restructuring Takes Shape

While the market watches the share price, management is executing a far-reaching strategic overhaul. The company is expanding its capacity for HALS and NOR-HALS products — plastic additives that protect polymers from UV radiation and weathering — at three production sites in Germany, Italy, and China. The investment is aimed squarely at the Chinese agricultural sector, where farmers are seeking durable films that can withstand extreme heat and aggressive chemicals while reducing plastic residue in the soil.

Should investors sell immediately? Or is it worth buying BASF?

These operational moves run parallel to a more dramatic corporate transformation. In the second quarter of 2026, BASF plans to sell its automotive coatings business to a consortium of funds led by Carlyle. The transaction values the division at €7.7 billion, with BASF expecting a pre-tax cash inflow of roughly €5.8 billion while retaining a 40% stake.

At the same time, preparations are underway for an initial public offering of the agricultural chemicals division. BASF intends to list the business as a European stock corporation in Frankfurt, with a dedicated divisional board taking over in May. The parent company will remain the majority shareholder.

Currency Headwinds and a Key Date on the Calendar

Despite the strategic progress, the operating environment remains challenging. A weak US dollar is taking a toll on earnings, with the currency effect alone costing up to €200 million in the first quarter. For the full year 2026, management is targeting operating profit between €6.2 billion and €7.0 billion, with the agriculture and materials segments feeling the most pressure from exchange rates.

All eyes are now on April 30. That morning at 7:00 AM MESZ, BASF will release its first-quarter results, followed by the annual general meeting later in the day. Shareholders will vote on a proposed dividend of €2.25 per share — a figure that compares with analyst expectations of €2.28 for 2026. If approved, the payout will reach investors in early May.

The Q1 report will be the first real test of whether the operational turnaround Citigroup anticipates is actually materializing. In the fourth quarter of 2025, BASF posted revenue of €14.03 billion — a sharp decline year-on-year — but managed to exit the loss zone operationally. Whether that trend continues will either validate Satz’s contrarian call or expose it to renewed skepticism.